SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-24-022704
Filing Date
2024-04-29
Accepted
2024-04-29 08:02:41
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq Description Document Type Size
1 ARS ny20023222x3_ars.pdf ARS 2297754
  Complete submission text file 0001140361-24-022704.txt   3165222
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39696 | Film No.: 24886669
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)